ArticleClinical and experimental immunology2025

Discovery and Phase 1 study of a novel monoclonal antibody against human IL-1β for the treatment of IL-1β-mediated diseases.

Minseon Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.